Volume : 3, Issue : 3, JUN 2019
A Review on Herbal Medicine: Past, Present and Future
Sunny Kumar, Bharat Parashar
Herbal medicine also referred to as herbalism is all about the study of botany and the use of plants intended for medicinal purposes. It involves the integration of different therapeutic experiences and practices based on indigenous systems of medicine that may effects many previous generations, which often leads to its valuable guidelines for the selection, preparation and application of herbal formulation for the disease or disorder treatment, control and management. Now days in this modern era people are bending themselves towards the organic life to stay healthy and also prefer the herbal medicine instead of allopathic. The result of hike in demand for herbal medicine, leads to the safety concern of herbal products regarding the standardization, efficacy, bioavailability, preservation and quality. This safety measure is taken care by the policy-makers, health professionals, manufacturer as well as the consumer. The Improvement in quality of herbal medicine can not only be done by taking care at the time of production or post marketing surveillance but it should be taken care at the time of cultivation too as it the basic step involved in the manufacturing process of the herbal medicine. The implementation of quality check during production as well as cultivation is providing the new strength to herbal medicine in market.
Herbalism, consumer, bioavailability, preservation, standardization.
Article : Download PDF
Cite This Article
Article No : 7
Number of Downloads : 2
1. Bent S (Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center). J Gen Intern Med .2008; 23: 854-859.
2. Falodun A (Herbal medicine in Africa-distribution, standardization and prospects) Res J Phytochem. 2010; 4: 154-161.
3. Ahmadullah, M. Nayar, M. P. Red data book of Indian Plants (Peninsular India): Botanical survey of India. Calcutta, (1999).
4. Barnes J, Anderson LA, Phillipson JD (Herbal medicine). 2007; 3rd Edition, Pharmaceutical Press, London. pp 1-23.
5. Kinghorn A.D. (The role of pharmacognosy in modern medicine), Expert Opin. Pharmacother. 2002, 3(2) 77-79.
6. Griggs B Green pharmacy: A history of herbal medicine. J Morman & Hobhouse Ltd. London.1981.
7. Kong JM, Goh NK, Chia LS, Chia TF (Recent advances in traditional plant drugs and orchids). Acta Pharmacol Sin 2003; 24: 7-21.
8. Philipeon JD (Phytochemistry and medicinal plants). Phytother 2003; 56: 237-243.
9. Sumner, Judith (The Natural History of Medicinal Plants). Timber Press.2000; p. 17. ISBN 978-0-88192-483-1.
10. Grover JK, Yadav S, Vats V (Medicinal plants of India with antidiabetic potential). J Ethnopharmacol 2002; 81: 81-100.
11. Goldman P1 (Herbal medicines today and the roots of modern pharmacology). Ann Intern Med 2001; 135: 594-600.
12. Brater DC, Daly WJ (Clinical pharmacology in the Middle Ages: principles that presage the 21st century). Clin Pharmacol Ther 2000; 67: 447-450.
13. Gurib-Fakim A (Medicinal plants: traditions of yesterday and drugs of tomorrow). Mol Aspects Med 2006; 27: 1-93.
14. Newman DJ, Cragg GM, Snader KM (Natural products as sources of new drugs over the period 1981-2002). J Nat Prod 2003; 66: 1022-1037.
15. Gupta R, Gabrielsen B, Ferguson SM (Nature's medicines: traditional knowledge and intellectual property management). Case studies from the National Institutes of Health (NIH), USA. Curr Drug Discov Technol 2005; 2: 203-219.
16. Lesney MS (Nature’s pharmaceuticals: Natural products from plants remain at the core of modern medicinal chemistry). TCAW 2004; 13: 26-31.
17. Bhardwaj S., Verma R, Gupta J., (Challenges and future prospect of Herbal Medicine), International Reesearch in Medical and Health Sciences, 2018; 1(1):12-15.
18. Mukherjee PW. (Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals). New Delhi, India: Business Horizons Publishers; 2002.
19. Ernst E, Schmidt K, Wider B. C (AM research in Britain: The last 10 years). Complement Ther Clin Pract 2005; 11:17-20.
20. Barnes PM, Bloom B, Nahin RL. (Complementary and alternative medicine use among adults and children: United States), 2007. Natl Health Stat Report 2008; 12:1-23.
21. Verma S, Singh SP, (Current and future status of herbal medicines). Vet World 2008; 1:347-50.
22. Moshi MJ. (Current and future prospects of integrating traditional and alternative medicine in the management of diseases in Tanzania). Tanzan Health Res Bull 2005; 7:159-67.
23. Russo M, Spagnuolo C, Tedesco I, Russo GL. (Phytochemicals in cancer prevention and therapy: Truth or dare?) Toxins (Basel) 2010; 2:517-51.
24. Kokate CK, Purohit AP and Gokhale SB. (Pharmacognosy). 49th ed. Pune: Nirali Prakashan; 2014.
25. Bhattacharya R, Reddy KR, Mishra AK. (Export strategy of ayurvedic products from India). Int J Ayurvedic Med 2014; 5:125-8.
26. Bandaranayake WM. (Quality control, screening, toxicity, and regulation of herbal drugs). In: Ahmad I, Aqil F, Owais M, editors. Modern Phytomedicine Turning Medicinal Plants into Drugs. Weinheim: Wiley-VCH GmbH and Co. KGaA; 2006. p. 25-57.
27. World Health Organization. National Policy on Traditional Medicine and Regulation of Herbal Medicines. Report of a World Health Organization Global Survey. Geneva, Switzerland: World Health Organization; 2005.
28. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, et al. (Health benefits of herbs and spices: the past, the present, the future). Med J Aust 2006; 185: S4-24.
29. http://umm.edu/health/medical/altmed/treatment/herbal-medicine [accessed on 25 February 2015].
30. WHO (Legal status of traditional medicines and complimentary/ alternative medicine: worldwide review).2001; WHO Publications pp.10-14.
31. Abdel-Azim NS, Shams KA, Shahat AAA, El-Missiry MM, Ismail SI et al. (Egyptian herbal drug industry: challenges and future prospects). Res J Med Plant 2011; 5: 136-144.
32. Zhang BB, Moller DE (New approaches in the treatment of type 2 diabetes). Curr Opin Chem Biol 2000; 4: 461-467.
33. Fokunang CN, Ndikum V, Tabi OY, Jiofack RB, Ngameni B, et al. (Traditional medicine: past, present and future research and development prospects and integration in the National Health System of Cameroon). Afr J Tradit Complement Altern Med 2011; 8: 284-295.
34. Chikezie PC, Ojiako OA(Herbal medicine: yesterday, Today and Tomorrrow) Altern Integr Med 2015; 4:3 http://dx.doi.org/10.4172/2327-5162.1000195
35. Tilburt JC, Kaptchuk TJ (Herbal medicine research and global health: an ethical analysis). Bull World Health Organ 2008; 86: 594-599.
36. Fokunang CN, Ndikum V, Tabi OY, Jiofack RB, Ngameni B, et al. (Traditional medicine: past, present and future research and development prospects and integration in the National Health System of Cameroon). Afr J Tradit Complement Altern Med 2011; 8: 284-295.
37. Ahmadullah, M., Nayar, M. P. Red data book of Indian Plants (Peninsular India): Botanical survey of India. Calcutta, (1999)
38. Bent, S, American Journal of Medicine, 116: 478-485 (2004).
39. Dubey, N.K., Kumar, R., Tripathi, P., Current Med 86: 37-41(2004).
40. De Smet, P. A. G. M. Aristolochia species, in Adverse Effects of Herbal Drugs, Spinger Verlag, Berlin 1, 7989 (1992).
41. NMPB, Centrally Assisted Schemes for Medicinal Plants, National Medicinal Plant Board, New Delhi, India. (2004).
42. Purohit, S. S., Vyas, S. P. Medicinal plant cultivationA scientific approach Agrobios, Jodhpur, India, 228. (2005)
43. WHO (2002) Traditional medicinal strategy 2002-2005. WHO Publication pp. 1-6.
44. Elujoba AA, Odeleye OM, Ogunyemi CM (2005) Traditional medicine development for medicinal and dental primary care delivery system in Africa. Afr J Tradit Compl Altern Med 2: 46-61
45. Department of Health (2004) Traditional health practitioners’ bill. Available from: http://www.doh.gov.za/docs/index.html [accessed on 25 February 2015].
46. Adelaja A (2006) Nigeria boosts research into traditional medicine. Available from: http://www.scidev.net/en/news/nigeria-boosts-researchinto-traditional-medicine.html [accessed on 25 February 2015].
47. Calixto JB (2000) Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 33: 179-189.
48. Piédrola G, Novo E, Escobar F, García-Robles R (2001) White blood cell count and insulin resistance in patients with coronary artery disease. Ann Endocrinol (Paris) 62: 7-10.
49. Yaryura-Tobias JA, Pinto A, Neziroglu F (2001) Anorexia nervosa, diabetes mellitus, brain atrophy, and fatty liver. Int J Eat Disord 30: 350-353.
50. Haq J (2004) Safety of medicinal plants. Pak J Med Res 43: 8 pages.
51. Gardhipuram PSK, Durairaji SK, Sorimuthu PS (Anti-diabetic activity of fruits of Terminalia chebula on streptozotocin-induced diabetic rats). J Health Sci 2006; 54: 283-291.
52. Aronson JK (Side effects of herbal medicines). Elsevier B.V. Amsterdam, Boston, Heidelberg.2009
53. Jiofack T, Ayissi I (Floristic evaluation of the Upper Nyong valley in Cameroon, Technical report). Cameroon Wildlife Conserv Soc 3: 50. 2006.
54. Acharya D, Shrivastava A (Indigenous Herbal Medicines: Tribal Formulations and Traditional Herbal Practices). 2008; 1stedn. Aavishkar Publishers, Jaipur-India. pp. 440.
55. Tanaka M, Misawa E, Ito Y, Habara N, Nomaguchi K, et al. (2006) Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull 29: 1418-1422.
56. Alvari A, Mehrnaz SO, Ahmad FJ, Abdin MZ (2012) Contemporary overview on clinical trials and future prospects of hepato-protective herbal medicines. Rev Recent Clin Trials 7: 214-223.
57. Van de Venter M, Roux S, Bungu LC, Louw J, Crouch NR, et al. (2008) Antidiabetic screening and scoring of 11 plants traditionally used in South Africa. J Ethnopharmacol 119: 81-86.
58. Rotblatt MD1 (1999) Herbal medicine: a practical guide to safety and quality assurance. West J Med 171: 172-175.
59. Sane RT (2002) Standardization, quality control and GMP for herbal drugs. Indian Drug 39: 184-190.
60. Rodrigues E, Barnes J. Pharmacovigilance of herbal medicines: The potential contributions of ethnobotanical and ethnopharmacological studies. Drug Saf 2013; 36:1-2.
61. Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000; 9:105-12.
62. Abdul G. Herbal Medicines: Present Status, Future Prospects. Available from: http://www.pharmabiz.com/NewsDetails.Aspx? Aid=78355&Sid=22.
63. Parashar B, Jasrotia N. Medicinal Mushrooms: A Blessing for Mankind. Asian J. Res. Pharm Sci., 12-15, 2(1), 2012.
64. Parashar B, Mahajan U. B., An Overview On Superdisintegrants., Research J. Pharm. And Tech., 466-73, 5(4), 2012.
65. Parashar B, Dhamijia K. H, Sharma R, An Ayurvedic Arena For Hypertension Treatment., Asian J. Pharm. Res, 54-58, Vol. 2(2),2012.
66. Dhiman B, Parashar B. & Chandel A.,Psyllium: Apotential Carrier To Control The Drug Dlivery., International research journal of Pharmacy., 39-44, 3(7), 2012.
67. Kant S,Parashar B, A Review On Bioavailability And Bioequivalence Study., International Journal Of Institutional Pharmacy And Life Sciences., 58-71,2(5), 2012.
68. Rana Manpreet, Dhamijia H, Parashar B, Sharma S, Ricinus Communis L. – A Review., International Journal Of Pharmtech Research, 1706-1711,4(4), 2012.
69. Parashar B, Yadav V, Maurya B, Sharma L, Natural Therapy Of Fungal Nail Disease: Review., The Pharma Innovation.,31-47,1 (4), 2012.
70. Parashar B, Chandel A, Gupta N, Kumar A, Sharma V.,An overview on gel formulation, Int. J. Pharm. rev. Res 1, 18-22, 2013.
71. Kumar Damit, Sharma Amit, Rajeev Garg; “Formation and Evaluation of Sublingual Tablet of Losartan Potassium”; Asian Journal of Pharmaceutical Research and Development; 2018; 6(4); 54-56.